Penurunan Hemoglobin Persisten Pascasectio Caesarea pada HELLP Syndrome: Laporan Kasus Tantangan Diagnostik dan Pendekatan Terapi Kortikosteroid
Unresolved Hemoglobin Decline After Cesarean Delivery in HELLP Syndrome: Diagnostic Challenges and the Role of Corticosteroid Therapy — A Case Report
DOI:
https://doi.org/10.25026/jsk.v8i1.2614Abstract
Placental abruption associated with severe preeclampsia and HELLP syndrome is a critical obstetric condition that may rapidly progress to hematologic complications. We report a 29-year-old woman, gravida 2 para 1, at 21–22 weeks’ gestation, presenting with abdominal pain and vaginal bleeding, with chronic hypertension and obesity. Initial evaluation revealed severe hypertension, anemia, leukocytosis, mild thrombocytopenia, and ultrasonographic intrauterine fetal death, suggesting placental abruption with superimposed preeclampsia and suspected partial HELLP syndrome. Emergency cesarean section under spinal anesthesia confirmed placental abruption intraoperatively. Postoperatively, progressive hemoglobin decline unresponsive to initial transfusion occurred, accompanied by thrombocytopenia and elevated coagulation markers despite relative hemodynamic stability, creating a dilemma between recurrent bleeding and microangiopathic hemolytic anemia. Exploratory relaparotomy under general anesthesia showed no active bleeding source, only diffuse oozing, supporting HELLP syndrome with consumptive coagulopathy. The patient required ICU care with mechanical ventilation and aggressive blood component transfusion for severe anemia. Adjunctive corticosteroid therapy improved.
Keywords: HELLP syndrome; microangiopathic hemolytic anemia; obstetric anesthesiology; placental abruption
Abstrak
Solusio plasenta yang disertai preeklampsia berat dan HELLP syndrome merupakan kondisi obstetri kritis yang dapat berkembang cepat menjadi gangguan hematologis dan multisistem yang mengancam nyawa. Dilaporkan seorang perempuan 29 tahun, gravida 2 para 1, usia kehamilan 21–22 minggu, datang keluhan nyeri perut dan perdarahan pervaginam, terdapat riwayat hipertensi kronik dan obesitas. Evaluasi awal menunjukkan hipertensi berat, anemia, leukositosis, trombositopenia ringan, serta ultrasonografi intrauterine fetal death adanya kecurigaan solusio plasenta dan superimposed preeklampsia dd/suspek partial HELLP syndrome. Pasien menjalani sectio caesarea emergensi dengan anestesi spinal, dan temuan intraoperatif solusio plasenta. Pascaoperasi terjadi penurunan hemoglobin progresif yang tidak responsif terhadap transfusi awal, disertai trombositopenia dan peningkatan marker koagulopati, meskipun hemodinamik relatif stabil, menimbulkan dilema antara perdarahan berulang dan anemia hemolitik mikroangiopatik. Re-laparotomi eksploratif tidak menemukan sumber perdarahan aktif, mendukung HELLP syndrome beserta koagulopati konsumtif. Pasien dirawat di ICU dengan ventilasi mekanik akibat anemia berat (Hb 4,7 g/dL). Transfusi komponen darah agresif disertai terapi kortikosteroid memberikan perbaikan klinis dan hematologis bermakna hingga pasien pulih dan dipulangkan.
Kata Kunci: anemia hemolitik; anestesiologi obstetric; HELLP syndrome; mikroangiopatik; solusio plasenta
References
[1] George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2023;388:654-66.
[2] McCrae KR. Thrombotic microangiopathy in pregnancy. Hematology Am Soc Hematol Educ Program. 2023;2023(1):737-44.
[3] Scully M, Cataland SR, Coppo P, et al. Consensus on the diagnosis and management of thrombotic microangiopathies. J Thromb Haemost. 2024;22:1001-12.
[4] Al-Khaffaf A, Green L, Hunt BJ. Obstetric haemorrhage and coagulopathy: transfusion and critical care perspectives. Anaesthesia. 2023;78(Suppl 1):72-82.
[5] Charbit B, Samain E. Hemostatic disorders in obstetric hemorrhage. Best Pract Res Clin Anaesthesiol. 2019;33(1):63–73.
[6] Daneese E. Clinical challenges and management of microangiopathic hemolytic anemia in pregnant women. Clin Challenges Manag. 2024;21(4):491-8.
[7] Chhabra S, Gandhi K, Raut S. Diagnostic dilemma in HELLP syndrome: bleeding versus hemolysis. J Obstet Gynaecol Res. 2022;48(12):3100-7.
[8] Widodo A, Rahman F, Sari MI. Management of critically ill post-cesarean section patient with antepartum hemorrhage and HELLP syndrome: a multidisciplinary approach. J Soc Med. 2025;4(7):1-8.
[9] Kasem AF, Alqenawy HB, Elgendi MA, Abdelrahman AM, Soliman MH. Corticosteroids for improving patient-relevant outcomes in HELLP syndrome: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024;24:487.
[10] Sun WJ, Hu J, Zhang Q, Shan JM. Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidence from seven randomized controlled trials. Hypertens Pregnancy. 2023;42(3):1–10.
[11] Cochrane Pregnancy and Childbirth Group. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev. 2019;(8):CD008148.
[12] Yulistiani Y, Rana R. The effect of corticosteroid administration on maternal outcomes in patients with HELLP syndrome. Eduvest J Universal Stud. 2024;4(6):741-9.
[13] Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of corticosteroids. Am J Obstet Gynecol. 2020;223(2):147–58.
[14] Pivalizza EG, et al. Perioperative management of severe preeclampsia and HELLP syndrome. Curr Opin Anaesthesiol. 2022;35(3):312–9.
[15] Gupta R, Choudhury N, Mishra S. Usage of blood components in obstetric practice: transfusion strategies and challenges. J Hematol Allied Sci. 2024;3:93-102.
[16] Shaylor R, Weiniger CF, Austin N, et al. National and international guidelines for patient blood management in obstetrics. Anaesthesia. 2017;72:112–30.
[17] Muñoz M, Acheson AG, Auerbach M, et al. International consensus statement on patient blood management. Anaesthesia. 2019;74(1):16–26.
[18] Liang Y, Chen Q, Wang X, Zhang L, Liu H, Zhao Y. Multidisciplinary management of concurrent postpartum eclampsia, HELLP syndrome, hepatic hematoma, and atypical hemolytic uremic syndrome: a case report. BMC Pregnancy Childbirth. 2025;25:1206.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Jurnal Sains dan Kesehatan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



